Related Experiment Video
Updated: Mar 16, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
Synthetic viability by BRCA2 and PARP1/ARTD1 deficiencies
Xia Ding1, Arnab Ray Chaudhuri2, Elsa Callen2
1Mouse Cancer Genetics Program, National Cancer Institute, NIH, Frederick, MD 21702, USA.
Poly (ADP-ribose) polymerase inhibitors kill BRCA2-deficient cells. However, inhibiting PARP before BRCA2 loss can lead to synthetic viability, offering a new therapeutic strategy for cancer treatment.
Area of Science:
- Genetics
- Molecular Biology
- Oncology
Background:
- Poly (ADP-ribose) polymerase inhibitors (PARPi) are effective against BRCA1/2-mutated cancers due to homologous recombination deficiency.
- The therapeutic effect of PARPi in homologous recombination-proficient cells remains less understood.
Purpose of the Study:
- To investigate the impact of PARPi on homologous recombination-proficient cells.
- To explore the mechanism of synthetic lethality and viability in the context of PARP and BRCA2 interactions.
Main Methods:
- Utilized Brca2(cko/ko) mouse embryonic stem cells (mESCs) with PARP1 knockdown or olaparib pretreatment.
- Assessed homologous recombination (HR) proficiency and replication fork stability.
- Evaluated tumorigenesis in Brca2(cko/cko) mice with Parp1 heterozygosity.
Main Results:
- PARP1 deficiency or inhibition did not restore HR in BRCA2-deficient cells but protected stalled replication forks from degradation.
- Olaparib pretreatment of HR-proficient cells led to viable Brca2(ko/ko) cells, indicating synthetic viability.
- Parp1 heterozygosity significantly increased tumorigenesis in the context of BRCA2 loss.
Conclusions:
- While olaparib is effective against BRCA2-deficient cancers, it can also induce synthetic viability when PARP is inhibited prior to BRCA2 loss.
- This finding suggests a potential therapeutic window for PARP inhibition in specific cancer contexts, even in HR-proficient cells.
Related Concept Videos
Restarting Stalled Replication Forks
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Fixing Double-strand Breaks
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Long-patch Base Excision Repair

